Key result
Oral appliance therapy reduces PAC index ~62% vs auto-CPAP in a patient with OSA and AF.
Why the study?
Sleep apnea-related autonomic responses may increase cardiac arrhythmias, and therapies for paroxysmal AF could benefit from adjunctive oral appliance therapy with a mouth shield compared to auto-adjusting positive airway pressure.
Does combination oral appliance therapy with a mouth shield improve cardiac electrophysiology and hemodynamics compared to APAP in a patient with OSA and paroxysmal AF?
Case Report (n=1)
No
Does combination oral appliance therapy with a mouth shield improve cardiac electrophysiology and hemodynamics compared to APAP in a patient with OSA and paroxysmal AF?
In a single patient with OSA and paroxysmal AF, oral appliance therapy with a mouth shield improved cardiac conduction and vascular function compared to APAP.
Answers are grounded in this paper and cite their sources.
May reduce atrial ectopy in OSA with paroxysmal AF; hypothesis-generating from one case and requires prospective trials.
Background and objectives Sleep apnea-related autonomic responses may increase cardiac arrhythmias. Ablation, cardioversion, and pharmacologic therapies for paroxysmal atrial fibrillation (AF) could benefit from adjunctive oral appliance therapy with a mouth shield (OAT+) compared to auto-adjusting positive airway pressure (APAP). Methods A 67-year-old male with moderate obstructive sleep apnea (OSA), AF history, three ablations, and on Carvedilol (10 mg daily) underwent home sleep recordings with APAP and with OAT+ after 4 weeks. Randomly selected premature atrial contractions (PACs; n=20) and time-linked plethysmography waves from each intervention were compared. Results OAT+ reduced the PAC index (-61.9%), cardiac conduction intervals (nR-R, p = 0.025; pre-PAC R-R, p = 0.003; R-PAC-R, p = 0.051; PAC R-post systolic pause-R, p < 0.001) except for a P-R interval increase ( p = 0.032). PAC-associated plethysmography wave amplitudes increased with OAT+ (pre-PAC wave-1, p < 0.001; PAC wave-2, p = 0.023; post-PAC wave-3, p < 0.001). Conclusions OAT+ shows promise as an adjunct AF therapy in OSA patients, improving cardiac conduction and vascular function over APAP.
No takes yet. Share an insight, caveat, or question.
Schramm et al. (2025) conducted a case report in Obstructive Sleep Apnea and Paroxysmal Atrial Fibrillation (n=1). Oral appliance therapy with a mouth shield (OAT+) vs. Auto-adjusting positive airway pressure (APAP) was evaluated on Premature atrial contraction (PAC) index (-61.9% change). Oral appliance therapy with a mouth shield reduced the premature atrial contraction index by 61.9% compared to auto-adjusting positive airway pressure in a patient with OSA and paroxysmal AF.
Synapse has enriched 10 related papers. Consider them for comparative context: